Click here to learn how you can leverage WCG's Placebo Response Reduction training for your clinical trial.
Want to read the abbreviated version of the poster? Click on this link to discover more.
Click here to learn how you can leverage WCG's Placebo Response Reduction training for your clinical trial.
Want to read the abbreviated version of the poster? Click on this link to discover more.
Blinded analyses were aimed to determine how different atypical Positive and Negative Syndrome Scale (PANSS) score profiles (identified using algorithms) were able to predict early termination.
The objective was to use a priori scoring algorithm designed to assess violations and non-violations on PANSS items.
The goal of this study was to identify a CDR quality metric, based upon internal patterns of domain scores that could be used to identify atypical patterns that might be indicative of scoring errors.
This study investigated the impact of lag time on error rates for commonly used Alzheimer’s disease COAs, as well as the degree to which administration attenuated error rates associated with lag time.
The goal of the present study was to examine the potential utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in prodromal AD trials.